Follow
Jiaye Liu
Jiaye Liu
School of Public Health, Shenzhen University
No verified email
Title
Cited by
Cited by
Year
Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020
J Liu, X Liao, S Qian, J Yuan, F Wang, Y Liu, Z Wang, FS Wang, L Liu, ...
Emerging infectious diseases 26 (6), 1320, 2020
11702020
The role of hepatitis B surface antigen in nucleos (t) ide analogues cessation among asian patients with chronic hepatitis B: a systematic review
J Liu, T Li, L Zhang, A Xu
Hepatology 70 (3), 1045-1055, 2019
1132019
Longitudinal Changes of Liver Function and Hepatitis B Reactivation in COVID‐19 Patients with Pre‐existing Chronic HBV Infection
J Liu, T Wang, Q Cai, L Sun, D Huang, G Zhou, Q He, FS Wang, L Liu, ...
Hepatology Research, 2020
74*2020
Effect of combination treatment based on interferon and nucleos (t) ide analogues on functional cure of chronic hepatitis B: a systematic review and meta-analysis
J Liu, T Wang, W Zhang, Y Cheng, Q He, FS Wang
Hepatology international 14, 958-972, 2020
332020
Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
J Lv, H Wu, J Xu, J Liu
Infectious Diseases of Poverty 11 (1), 53, 2022
292022
Immune response to hepatitis B vaccine in patients with chronic hepatitis C infection: A systematic review and meta‐analysis
J Liu, H Wu, H Chen
Hepatology Research 48 (2), 119-126, 2018
252018
Immune restoration in HIV-1-infected patients after 12 years of antiretroviral therapy: a real-world observational study
J Liu, L Wang, Y Hou, Y Zhao, Z Dou, Y Ma, D Zhang, Y Wu, D Zhao, Z Liu, ...
Emerging Microbes & Infections 9 (1), 2550-2561, 2020
242020
Comparison between two population-based hepatitis B serosurveys with an 8-year interval in Shandong Province, China
J Liu, J Lv, B Yan, Y Feng, L Song, A Xu, L Zhang, Y Yan
International Journal of Infectious Diseases 61, 13-19, 2017
172017
Comparison of hepatitis E virus seroprevalence between HBsAg-positive population and healthy controls in Shandong province, China
L Zhang, Z Jiang, J Lv, J Liu, B Yan, Y Feng, L Li, G Zhang, F Wang, A Xu
BMC Infectious Diseases 18, 1-9, 2018
162018
Human umbilical cord mesenchymal stem cell transfusion in immune non-responders with AIDS: a multicenter randomized controlled trial
L Wang, Z Zhang, R Xu, X Wang, Z Shu, X Chen, S Wang, J Liu, Y Li, ...
Signal transduction and targeted therapy 6 (1), 217, 2021
142021
Evolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years …
LQ Sun, JY Liu, Y He, Y Zhou, LM Xu, LK Zhang, F Zhao, XN Liu, Y Song, ...
Chinese medical journal 133 (23), 2808-2815, 2020
132020
High population-attributable fractions of traditional risk factors for non-AIDS-defining diseases among people living with HIV in China: a cohort study
J Liu, Y Hou, L Sun, L Wang, Y He, Y Zhou, L Xu, X Liu, F Zhao, L Zhang, ...
Emerging microbes & infections 10 (1), 416-423, 2021
122021
Barriers to early diagnosis and treatment of severely immunosuppressed patients with HIV‐1 infection: A quantitative and qualitative study
JY Liu, LQ Sun, YY Hou, LF Wang, Y He, Y Zhou, LM Xu, H Wang, ...
HIV medicine 21 (11), 708-717, 2020
72020
Higher risk of dyslipidemia with coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide than efavirenz, lamivudine, and tenofovir disoproxil fumarate …
L Sun, Y He, L Xu, F Zhao, Y Zhou, L Zhang, Q Peng, H Zhang, Q Zhang, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 91 (S1), S8-S15, 2022
62022
Epidemiological trends of severely immunosuppressed people living with HIV at time of starting antiretroviral treatment in China during 2005–2018
Y Hou, J Liu, Y Zhao, Y Wu, Y Ma, D Zhao, Z Dou, Z Liu, M Shi, Y Jiao, ...
Journal of Infection 84 (3), 400-409, 2022
62022
Total dietary flavonoid intake and risk of cardiometabolic diseases: A dose-response meta-analysis of prospective cohort studies
T Li, Y Zhao, L Yuan, D Zhang, Y Feng, H Hu, D Hu, J Liu
Critical Reviews in Food Science and Nutrition 64 (9), 2760-2772, 2024
52024
Matching study on immune response between single anti-HBc positivity and healthy adults after primary immunization and revaccination of hepatitis B vaccine
J Liu, J Lyu, B Yan, Y Feng, L Zhang, A Xu
Zhonghua liu Xing Bing xue za zhi= Zhonghua Liuxingbingxue Zazhi 35 (10 …, 2014
52014
Comparison on the Antibody Response and Influenced Factors of Hepatitis B Vacine Made by Recombinant Dexyribonucleic Acid Techniques among Adults
J Liu, B Yan, L Zhang, J Lv, Y Feng, F Ji, S Chen, A Xu
Chin. J. Vaccines Immun 19, 142-146, 2013
52013
Dating the origin and dispersal of global hepatitis B virus genotype C in humans
T Li, H Chen, L Sun, J Liu
Drug discoveries & therapeutics 16 (2), 85-92, 2022
42022
Longitudinal changes on clinical features in 28 children with COVID-19 in Shenzhen, China
X Liao, J Liu, Z He, M Hu, T Xiao, L Wei, Q Cai, H Wang, Q He, L Liu, ...
Frontiers in Medicine 7, 738, 2020
42020
The system can't perform the operation now. Try again later.
Articles 1–20